← back to search

Emily Z. Keung

The University of Texas MD Anderson Cancer Center · US
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, and Melanoma and MAPK Pathways.
h-index
34
citations
8,684
works
224
NIH funding
primary concept
Medicine
email

Recent publications

Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Annals of Surgical Oncology 2025cited by 1position: middledoi
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Annals of Surgical Oncology 2025cited by 0position: middledoi
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Annals of Surgical Oncology 2025cited by 0position: middledoi
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Nature Cancer 2024cited by 53position: middledoi
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Nature 2022cited by 326position: middledoi
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Nature 2022cited by 130position: middledoi
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
Frontiers in Oncology 2022cited by 52position: middledoi
Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas
Annals of Surgery 2022cited by 12position: middledoi
B cells and tertiary lymphoid structures promote immunotherapy response
Nature 2020cited by 2,612position: middledoi
B cells are associated with survival and immunotherapy response in sarcoma
Nature 2020cited by 1,886position: middledoi
Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma
European Journal of Surgical Oncology 2017cited by 105position: firstdoi
Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
Cell Reports 2017cited by 97position: middledoi
Dual Roles of RNF2 in Melanoma Progression
Cancer Discovery 2015cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2025–2025) · 3 papers (2025–2025)David Gyorki · Peter MacCallum Cancer Centre3 papers (2025–2025)Michael J. Wagner · Dana-Farber Cancer Institute3 papers (2025–2025) · 3 papers (2025–2025) · 3 papers (2025–2025)Max Almond · University of Birmingham3 papers (2025–2025)Giovanni Grignani · Hospital Universitario Fundación Jiménez Díaz3 papers (2025–2025)Adam D. Barlow · University of Leicester3 papers (2025–2025)Carolyn Nessim · Sunnybrook Health Science Centre3 papers (2025–2025)Lee D. Cranmer · City of Hope3 papers (2025–2025) · 3 papers (2025–2025)Alessandro Gronchi · Dana-Farber Cancer Institute3 papers (2025–2025)Markus Albertsmeier · Ludwig-Maximilians-Universität München3 papers (2025–2025)Bruno Vincenzi · Università Campus Bio-Medico3 papers (2025–2025)Aviram Nissan · Bar-Ilan University3 papers (2025–2025)Jason L. Hornick · Dana-Farber Brigham Cancer Center3 papers (2025–2025)Petko Fiziev · Illumina (United States)1 papers (2015–2015) · 1 papers (2015–2015)Christina L. Roland · The University of Texas MD Anderson Cancer Center1 papers (2017–2017)